CD8A and diabetes mellitus: However, it was demonstrated that inhibition of the PD-1 pathway may disrupt intestinal tolerance, trigger CD8 T cells (Reynoso et al., 2009), disrupt Th2 polarization (Schwartz et al., 2017), and aggrieve diabetes (Yun et al., 2020; Kotwal et al., 2019).